Publikationen von Hannelore Ehrenreich

Hagemeyer, N.; Boretius, S.; Ott, C.; Streitberg, A. v.; Welpinghus, H.; Sperling, S.; Frahm, J.; Simons, M.; Ghezzi, P.; Ehrenreich, H.: Erythropoietin attenuates neurological and histological consequences of toxic demyelination in mice. Molecular Medicine 18 (4), S. 628 - 635 (2012)

Treiber, H.; Hagemeyer, N.; Ehrenreich, H.; Simons, M.: BACE1 in central nervous system myelination revisited. Molecular Psychiatry 17 (3), S. 237 - 239 (2012)

Kobe, F.; Guseva, D.; Jensen, T. P.; Wirth, A.; Renner, U.; Hess, D.; Müller, M.; Medrihan, L.; Zhang, W.; Zhang, M. et al.; Braun, K.; Westerholz, S.; Herzog, A.; Radyushkin, K.; El-Kordi, A.; Ehrenreich, H.; Richter, D. W.; Rusakov, D. A.; Ponimaskin, E.: 5-HT₇R/G₁₂ signaling regulates neuronal morphology and function in an age-dependent manner. Journal of Neuroscience 32 (9), S. 2915 - 2930 (2012)

Miskowiak, K. W.; Vinberg, M.; Harmer, C. J.; Ehrenreich, H.; Kessing, L. V.: Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression. Psychopharmacology 219 (3), S. 687 - 698 (2012)

Ehrenreich, H.; Kästner, A.; Weissenborn, K.; Streeter, J.; Sperling, S.; Wang, K. K.; Worthmann, H.; Hayes, R. L.; Ahsen, N. v.; Kastrup, A. et al.; Jeromin, A.; Herrmann, M.: Circulating damage marker profiles support a neuroprotective effect of erythropoietin in ischemic stroke patients. Molecular Medicine 17 (11-12), S. 1306 - 1310 (2011)

Steinberg, S.; Jong, S. d.; Andreassen, O.; Werge, T.; Børglum, A. D.; Mors, O.; Mortensen, P. B.; Gustafsson, O.; Costas, J.; Pietiläinen, O. P. H. et al.; Demontis, D.; Papiol, S.; Huttenlocher, J.; Mattheisen, M.; Breuer, R.; Vassos, E.; Giegling, I.; Fraser, G.; Walker, N.; Tuulio-Henriksson, A.; Suvisaari, J.; Lönnqvist, J.; Paunio, T.; Agartz, I.; Melle, I.; Djurovic, S.; Strengman, E.; Jürgens, G.; Glenthøj, B.; Terenius, L.; Hougaard, D. M.; Ørntoft, T.; Wiuf, C.; Didriksen, M.; Hollegaard, M. V.; Nordentoft, M.; Winkel, R. v.; Kenis, G.; Abramova, L.; Kaleda, V.; Arrojo, M.; Sanjuán, J.; Arango, C.; Sperling, S.; Rossner, M.; Ribolsi, M.; Magni, V.; Siracusano, A.; Christiansen, C.; Kiemeney, L. A.; Veldink, J.; Van den Berg, L.; Ingason, A.; Muglia, P.; Murray, R.; Nöthen, M. M.; Sigurdsson, E.; Petursson, H.; Thorsteinsdottir, U.; Kong, A.; Rubino, I. A.; Hert, M. d.; Réthelyi, J. M.; Bitter, I.; Jönsson, E. G.; Golimbet, V.; Carracedo, A.; Ehrenreich, H.; Craddock, N.; Owen, M. J.; O'Donovan, M. C.; Ruggeri, M.; Tosato, S.; Peltonen, L.; Ophoff, R. A.; Collier, D. A.; St Clair, D.; Rietschel, M.; Cichon, S.; Stefansson, H.; Rujescu, D.; Stefansson, K.: Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Human Molecular Genetics 20 (20), S. 4076 - 4081 (2011)

Papiol, S.; Malzahn, D.; Kästner, A.; Sperling, S.; Begemann, M.; Stefansson, H.; Bickeböller, H.; Nave, K.-A.; Ehrenreich, H.: Dissociation of accumulated genetic risk and disease severity in patients with schizophrenia. Translational Psychiatry, e45 (2011)

Lang, N.; Rothkegel, H.; Reiber, H.; Hasan, A.; Sueske, E.; Tergau, F.; Ehrenreich, H.; Wuttke, W.; Paulus, W.: Circadian modulation of GABA-mediated cortical inhibition. Cerebral Cortex 21 (10), S. 2299 - 2306 (2011)

Ribbe, K.; Ackermann, V.; Schwitulla, J.; Begemann, M.; Papiol, S.; Grube, S.; Sperling, S.; Friedrichs, H.; Jahn, O.; Sillaber, I. et al.; Gefeller, O.; Krampe, H.; Ehrenreich, H.: Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor system. Archives of General Psychiatry 68 (12), S. 1247 - 1256 (2011)

Sargin, D.; El-Kordi, A.; Agarwal, A.; Müller, M.; Wojcik, S. M.; Hassouna, I.; Sperling, S.; Nave, K.-A.; Ehrenreich, H.: Expression of constitutively active erythropoietin receptor in pyramidal neurons of cortex and hippocampus boosts higher cognitive functions in mice. BMC Biology 9, 27 (2011)

Papiol, S.; Begemann, M.; Rosenberger, A.; Friedrichs, H.; Ribbe, K.; Grube, S.; Schwab, M. H.; Jahn, H.; Gunkel, S.; Benseler, F. et al.; Nave, K.-A.; Ehrenreich, H.: A phenotype-based genetic association study reveals the contribution of neuregulin1 gene variants to age of onset and positive symptom severity in schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 156 (3), S. 340 - 345 (2011)

Grube, S.; Gerchen, M. F.; Adamcio, B.; Pardo, L. A.; Martin, S.; Malzahn, D.; Papiol, S.; Begemann, M.; Ribbe, K.; Friedrichs, H. et al.; Radyushkin, K. A.; Müller, M.; Benseler, F.; Riggert, J.; Falkai, P.; Bickeböller, H.; Nave, K.-A.; Brose, N.; Stühmer, W.; Ehrenreich, H.: A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia. Embo Molecular Medicine 3 (6), S. 309 - 319 (2011)

Krampe, H.; Spies, C. D.; Ehrenreich, H.: Supervised disulfiram in the treatment of alcohol use disorder: a commentary. Alcoholism: Clinical and Experimental Research 35 (10), S. 1732 - 1736 (2011)

Ostrowski, D.; Ehrenreich, H.; Heinrich, R.: Erythropoietin promotes survival and regeneration of insect neurons in vivo and in vitro. Neuroscience 188, S. 95 - 108 (2011)

Sussulini, A.; Dihazi, H.; Muller Banzato, C. E.; Zezzi Arruda, M. A.; Stühmer, W.; Ehrenreich, H.; Jahn, O.; Kratzin, H. D.: Apolipoprotein A-I as a candidate serum marker for the response to lithium treatment in bipolar disorder. Proteomics 11 (2), S. 261 - 269 (2011)

Wüstenberg, T.; Begemann, M.; Bartels, C.; Gefeller, O.; Stawicki, S.; Hinze-Selch, D.; Mohr, A.; Falkai, P.; Aldenhoff, J. B.; Knauth, M. et al.; Nave, K.-A.; Ehrenreich, H.: Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia. Molecular Psychiatry 16 (1), S. 26 - 36 (2011)

Wüstenberg, T.; Begemann, M.; Bartels, C.; Gefeller, O.; Stawicki, S.; Hinze-Selch, D.; Mohr, A.; Falkai, P.; Aldenhoff, J.; Knauth, M. et al.; Nave, K. A.; Ehrenreich, H.: EPO treatment preserves gray matter in discrete brain regions of chronic schizophrenic patients: indication of areas with most progressive neurodegeneration inherent to the disease process. Molecular Psychiatry 16, 1 (2011)

Ribbe, K.; Friedrichs, H.; Begemann, M.; Grube, S.; Papiol, S.; Kästner, A.; Gerchen, M. F.; Ackermann, V.; Tarami, A.; Treitz, A. et al.; Flögel, M.; Adler, L.; Aldenhoff, J. B.; Becker-Emner, M.; Becker, T.; Czernik, A.; Dose, M.; Folkerts, H.; Freese, R.; Guenther, R.; Herpertz, S.; Hesse, D.; Kruse, G.; Kunze, H.; Franz, M.; Lohrer, F.; Maier, W.; Mielke, A.; Müller-Isberner, R.; Oestereich, C.; Pajonk, F.-G.; Pollmächer, T.; Schneider, U.; Schwarz, H.-J.; Kröner-Herwig, B.; Havemann-Reinecke, U.; Frahm, J.; Stühmer, W.; Falkai, P.; Brose, N.; Nave, K.-A.; Ehrenreich, H.: The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients. BMC Psychiatry 10, 91 (2010)

Miskowiak, K. W.; Vinberg, M.; Harmer, C. J.; Ehrenreich, H.; Knudsen, G. M.; Macoveanu, J.; Hansen, A. R.; Paulson, O. B.; Siebner, H. R.; Kessing, L. V.: Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder. Trials 11 (1), 97 (2010)

Bartels, C.; Wegrzyn, M.; Wiedl, A.; Ackermann, V.; Ehrenreich, H.: Practice effects in healthy adults: a longitudinal study on frequent repetitive cognitive testing. BMC Neuroscience 11, 118 (2010)